GB Group Ord Shs GBGPF

GB Group plc is a United Kingdom-based company, which provides identity data intelligence products and services helping organizations recognize and verify all elements of an individual's identity at key interactions in their business processes. The Company's segments include location, identity and fraud. The location segment includes address lookup, verification and capture; e-mail validation; phone verification, and data maintenance services. The identity segment includes document verification, data verification and identity investigation services. Its identity verification solutions can be configured to carry out a wide range of functions, including know your customer checks, anti-money laundering checks, age verification checks and liveness detection. The fraud segment includes transaction fraud monitoring, combating origination fraud and in-life fraud investigation services. It provides artificial intelligence powered screening for automatic onboarding or referral of customers.

OTCPK:GBGPF - Post by User

GB Group Ord Shs > Comparing ACB at $13.48 with CMED at $1.88

<< Previous

Bullboard Posts

Next >>

Comment by Supermariogon Jan 20, 2018 11:34am

131 Views

Post# 27400662

RE:Comparing ACB at $13.48 with CMED at $1.88

It really looks like you are not scared to look ridicule :-) Number of shares is only a part of value. Market is FORWARD thinking. The future of CMED (if past is giving an idea of future) is to be the slowly growing company they use to be. Obviously this allow them to built good products etc... ACB building a 100,000 sq.ft greenhouse in Denmark (120,000 Kg/year), and also a 800,000 in Edmonton plus some in Qubec, etc..they own the largest German pharmacy distributor, they just became the first (and only for the moment) suppler of Cannabis to Italy, they own the best in the world greenhouse builder, etc... etc. Please try to be at least a little bit correct when you try to teach the newbies... so sad reading you. SM

MartialArts wrote:
One of the very, very common problems novices have is evaluating and comparing share prices. Talk to anyone new to investing or trading and everyone has the same issue. It's part of the "maturing" process on the markets. Once you can evaluate a company on market cap and enterprise value, you can shed off the "newbie" moniker.

In order to compare two companies on equal footing, you need to compare them with the same number of issued shares. That seems to be the best way to do it.

So Aurora has a market cap of $6.10B with 452.73M shares issued so the share price is $6100M/452.7 = $13.48 per share.

Now to compare Cannimed share price to Aurora, we really need to use the same number of issued shares otherwise we are comparing difference coins (loonies to nickels where CMED is denominated in loonies and ACB is denominated in nickels). Or "apples to oranges".

So taking Cannimed's market cap of $849M with the same ACB share count of 452.73M, we get
$849M/452.73m shares= $1.88 per share comparing apples to apples. Or total market cap denominated in nickels.

Hope that makes sense. If you have any questions please send me a message if you are scare to be riduculed. Everyone has been a newbie at some point in their lives. Nobody is born with this knowledge.